Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
J Clin Invest. 2020 Nov 2;130(11):6021-6033. doi: 10.1172/JCI138473.
J Clin Invest. 2020.
PMID: 32780725
Free PMC article.
Clinical Trial.